TMCnet News
RightEye Releases First Technology that Helps Uncover and Treat Functional Vision Issues; Marks Milestone for Optometry IndustryLAS VEGAS and BETHESDA, Md., Sept. 18, 2019 /PRNewswire/ -- RightEye LLC, an award-winning health technology company that uses eye tracking to improve vision performance, is proud to release its fully commercialized version of EyeQ Trainer, a game-changing oculomotor exercise program. Paired with its suite of EyeQ Tests, RightEye now offers a complete solution for addressing functional vision impairments faced by millions of Americans. The product will showcase at Vision Expo West taking place September 18-21, 2019 in Las Vegas (RightEye booth LP9109) and is available online starting tomorrow for prescribers. RightEye EyeQ Trainer features a completely revamped user experience that is more fun and easier to use through gamified features. The commercialized version incorporates feedback from hundreds of doctors who participated in a year-long beta test of the product. The new product also adds flexibility to both workflows and the user experience so doctors have more control and patients have more choices. RightEye's FDA-cleared eye-tracking system has already been adopted by nearly 700 optometrists and other providers, and more than 200,000 functional vision tests have been conducted. However, while RightEye's eye-tracking tests have become the leading tool for uncovering functional vision issues, many primary care optometrists have been asking for an accompanying treatment solution. The solution: EyeQ Trainer at-home oculomotor training program. Under the supervision of a health care provider, customized computer-based exercises are automatically assigned to patients when deficiencies are identified by RightEye's eye-tracking EyeQ Tests. Why EyeQ Trainer is Needed The Solution is Here EyeQ Trainer exercises are automatically assigned based on RightEye's existing eye-tracking EyeQ Tests. Exercises take about ten minutes per sitting, and can be completed using any computer or tablet, which the patient does for up to 30 days. After the patient has completed their prescribed training program, they return to their provider for retesting. "Today marks a major milestone for both RightEye and for the optometry market. We now offer a complete functional vision platform that can be easily utilized by any primary care optometrist," said Adam Gross, RightEye co-founder and CEO. "Doctors spoke and RightEye listened. By fusing EyeQ Trainer to our award-winning EyeQ Tests, we can help improve the lives of millions while creating new revenue opportunities for our providers." RightEye EyeQ Trainer activates the eyes' muscles, as well as key elements of brain circuitry. The circuitry activation results in better functional vision, and smoother and more accurate eye movements that directly impact quality of life. The result is training of all 12 muscles of the eyes, while signals from the brain are strengthened. According to RightEye data, patients using EyeQ Trainer experienced an improvement of up to 17% in their functional vision measurements after just one week of use, and 93% of patients reported feeling better. "During the past fifty years, there have been just a handful of significant technology shifts in the eye care industry and RightEye is one of them. It adds a completely new dimension for vision care," said Kristopher May, OD, FAAO. "Beyond addressing refractive error to improve visual acuity and assess ocular health problems, I can now fully evaluate and treat functional vision issues. RightEye enables us to offer a truly comprehensive vision exam to address the needs of many more patients." Applications for EyeQ Trainer include:
EyeQ Trainer will be available to RightEye Providers beginning September 19th . For more information visit www.RightEye.com. About RightEye LLC Media Contact: Michele Gray View original content:http://www.prnewswire.com/news-releases/righteye-releases-first-technology-that-helps-uncover-and-treat-functional-vision-issues-marks-milestone-for-optometry-industry-300920639.html SOURCE RightEye LLC |